Wealthcare Advisory Partners’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
– Sell
-409
Closed -$80K – 1570
2021
Q1
$80K Buy
+409
New +$83.9K 0.01% 735
2020
Q2
– Sell
-150
Closed -$14K – 1122
2020
Q1
$14K Buy
+150
New +$14.5K ﹤0.01% 831

Other funds holding RGEN

Wealthcare Advisory Partners's RGEN Position: Q2 2021 in Review

Wealthcare Advisory Partners sold out of Repligen (RGEN) in Q2 2021, closing a stake of 409 shares — an estimated $80K sold.

Wealthcare Advisory Partners first reported a position in RGEN in Q1 2020 and held it in 2 quarters. The position peaked at $80K in Q1 2021. 429 funds tracked by Wall St. Rank hold RGEN as of Q2 2021.

  • Wealthcare Advisory Partners reported no remaining Repligen position as of Q2 2021 after selling out during the quarter.
  • Wealthcare Advisory Partners sold 409 Repligen shares in Q2 2021, an estimated $80K.
  • Wealthcare Advisory Partners first reported a position in Repligen in Q1 2020 and held it in 2 quarters.
  • Wealthcare Advisory Partners's Repligen position peaked at $80K in Q1 2021.
  • 429 funds tracked by Wall St. Rank held Repligen as of Q2 2021.

Based on Wealthcare Advisory Partners's 13F filing for Q2 2021, filed 16 Aug 2021.